Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Capital Raise Reality
View:
Post by made2last on Jun 18, 2024 1:40pm

Capital Raise Reality

Hi all;

menoalittle, while we suffer the liquidation of shares to pay for the new share offering, we can all rejoice in knowing that the inflow of capital is needed to pry open the doors to success. You know, No Pain, No Gain!

The best of luck to all;

made2last
Comment by menoalittle on Jun 18, 2024 2:25pm
Oh, it's not the dilution that irks me.  Far from it (as I quite well understand how the market works.). It's the simple fact that some of the (supposedly wealthy) folk wanting to participate in the pp don't see or understand that this is the wrong play to make at this point in time.  Yes, I know that may have worked nicely for them in the past.  But this time around is ...more  
Comment by menoalittle on Jun 18, 2024 3:32pm
In case it wasn't clear that I was referring to those that were currently selling TLT stock in order to (hopefully) participate in this upcoming pp... well, that's what I am specifically calling out as being doubly dumb, and the wrong play to make right now.
Comment by plantrader on Jun 18, 2024 3:34pm
What makes you so sure that you know more than they do, and that it's a dumb play? They've never been wrong, so far, unfortunately. 
Comment by menoalittle on Jun 18, 2024 3:57pm
Maybe I do, maybe I don't.  Call it a hunch if you want, but I've been around the block a time or two here and have never made this sorta call before around any of the previous placements.  And I suppose whether I'm right or wrong about it will be clear soon enough. (Before the leaves fall, if not much sooner...) But I won't mention it again. It is what it is.
Comment by plantrader on Jun 18, 2024 4:00pm
Ok fair enough. We'll see, and let's hope unomorethanalittle on this one.
Comment by CancerSlayer on Jun 18, 2024 3:43pm
Well said.... Although the time cost can weight heavily on people's minds, I'm always reconsidering/rebalancing my financial position with company risk.  Each derisking event changes that balance & hence my performance expectations.  We've been swamped with a lot of derisking events in the past month (both clincially & preclinically).  The amount of dilution ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250